Wie sind die Öffnungszeiten?

Montag 08:00 - 18:00 Dienstag 08:00 - 16:30 Mittwoch 08:00 - 18:00 Donnerstag 08:00 - 18:00 Freitag 08:00 - 16:30

CeGaT GmbH

Name: CeGaT GmbH
Address: Paul-Ehrlich-Straße 23, Tübingen, 72076, DE
Telephone: +4970715654455
Price range: $$
Rating: 5

CeGaT GmbH is a global provider of genetic analyses for various medical and research applications.
(2)

CeGaT GmbH, founded in Tübingen, Germany, is a world leader in gene analyses for a wide range of medical, research, and pharmaceutical applications. The company combines the latest sequencing technology with its many years of medical expertise – dedicated to identifying the genetic cause of disease and supporting patient care. For research and the pharmaceutical industry, CeGaT offers a broad port

folio of sequencing services and tumor analyses. CeGaT generates the data basis for clinical studies and medical innovations and drives science forward with own findings. The owner-managed company stands for independence, an extensive personal customer service, and the highest quality. To maintain the best results, all project steps are carried out in-house and under scientific supervision. CeGaT's laboratory is accredited according to CAP/CLIA and DIN EN ISO 15189, hence meeting high international standards.

09/06/2026

Are you attending ESHG 2026 in Gothenburg? Are you keen on meeting the CeGaT team? Swipe through to see who is waiting for you at booth 506. Learn more about our Meet the Expert sessions and scientific poster presentation. Save the dates and join us!

More information on our website: www.cegat.com/eshg-2026

08/06/2026

World Brain Tumor Day
Glioblastoma is one of the most aggressive brain tumors. Progress in treatment options has been slow – but precision medicine is opening new avenues.

World Brain Tumor Day reminds us of the urgent need for better treatment options – a need our subsidiary cecava GmbH is addressing. cecava develops individualized peptide cancer therapies (INPECT). INPECT translates genetic insights about patient-specific tumor mutations into a personalized immunotherapy. The goal is to specifically trigger the immune system to recognize and kill the patient’s tumor cells. More than 500 glioblastoma patients have been treated with this approach. The results are extremely promising. This is why cecava will start a phase I clinical trial for glioblastoma patients.

Learn more: www.cecava.com

28/05/2026

Are you planning to attend ESHG 2026 in Gothenburg?

Visit our team at booth 506 and discuss your topics directly with our experts. From genetic diagnostics to sequencing projects for research and biotech, our team will be available throughout the conference.

You can also join our “Meet the Expert” sessions on exome and tumor diagnostics and visit the poster presentation by Dr. Alexander Pepler.

For further information, session details, and meeting opportunities, please take a look at our ESHG 2026 page: www.cegat.com/eshg-2026

📍 ESHG 2026 | Gothenburg, Sweden
📅 June 13–15

13/05/2026

Meet Dr. Lisa Mertens at the Congress of the Neurological Association of South Africa (NASA), taking place May 13–16 in East London, South Africa. Visit her at table 2 and join her presentation on:

“Genetic diagnostics in neurology: the role of repeat expansions”
Friday, May 16 | 14:55
Auditorium

Repeat expansions are specific types of genetic alterations in which short DNA sequences are repeated excessively. They are an important cause of several neurological disorders, including cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) and spinocerebellar ataxia type 27B (SCA27B).

Many repeat expansions cannot be reliably detected using standard sequencing approaches and therefore require dedicated analysis methods. Only a limited number of diagnostic providers offer these specialized analyses.

As part of our Diagnostic Panel for Neurodegenerative Diseases, we offer analysis of 𝘙𝘍𝘊1 repeat expansions associated with CANVAS as well as 𝘍𝘎𝘍14 repeat expansions linked to SCA27B.

In addition to our Diagnostic Panel for Neurodegenerative Diseases, we also offer:
• Diagnostic Panel for Neuromuscular Diseases
• Diagnostic Panel for Epilepsy and Brain Development Disorders

Dr. Lisa Mertens is looking forward to connecting with clinicians and researchers in neurology and neurogenetics.

12/05/2026

Hereditary connective tissue diseases can present with highly variable and overlapping symptoms across multiple organ systems. This often makes a clear diagnosis challenging.

To support more precise diagnostics, we have updated our Diagnostic Panel for Connective Tissue Diseases with eight additional clinically relevant genes aligned with current research.

Genetic testing helps enable accurate diagnosis, informed risk assessment, and confident clinical decision-making.

07/05/2026

In healthcare and research, information security is essential. It is the basis for protecting sensitive data and trusting collaboration with clinical and industrial partners.

With the NIS 2 Directive, the EU is significantly increasing cybersecurity requirements.

At CeGaT, the requirements of the NIS 2 Directive align with already established and systematically developed structures. Internal processes are based on DIN EN ISO/IEC 27001 and follow an internationally recognized approach to structured information security management. A certificate confirms compliance with DIN EN ISO/IEC 27001:2024-01.

For our customers, this means a secure and stable environment for their data and projects. They can rely on consistent protection of sensitive information and clearly defined processes for handling security risks. This supports stable operations and ensures that security measures are continuously reviewed and improved.

Read more in our news article: www.cegat.com/cybersecurity-at-cegat-part-of-daily-practice

06/05/2026

Wanchai Saeli and Nick Wongsriphisant represent CeGaT at the Thai Society of Human Genetics 5th Annual Conference (TSHG2026), held from May 6–8 in Bangkok, Thailand.

If you are attending TSHG2026, feel free to stop by and connect with our team in Bangkok. We look forward to insightful discussions with the human genetics community across Asia.

30/04/2026

Today we are attending the I Jornada de Biologia del Càncer organized by the Societat Catalana de Biologia (SCB).

Come and learn more about CeGaT’s services in translational oncology, transcriptomics, single-cell analysis, and multi-omics approaches.

Marina Lorente Picón, PhD, will be happy to discuss your projects and potential collaborations.

29/04/2026

Which Single-Cell Sequencing Product Fits Your Research?

Single-cell RNA sequencing delivers powerful insights, but only if you choose the product that matches your sample type and research goals.

At CeGaT, we guide you to the right approach. With extensive experience and end-to-end support, we provide full-service solutions using 10x Genomics® technology:

✔ 3’ Single Cell Sequencing (3’ SCR)
✔ Single-Cell Immune Profiling (SIP)
✔ Single-Cell RNA Sequencing Flex (SCR Flex)

From primary sample to final data, we follow proven protocols with precision to ensure your sample is in expert hands.

Curious about how these approaches differ — and which one is right for your project? We’ve summarized it for you in a blog post: https://cegat.com/the-manifold-approaches-of-single-cell-rna-sequencing/

Looking for something different? We also offer Spatial Transcriptome Sequencing.

Please reach out to us to discuss your specific needs.

23/04/2026

The Work Behind Your Data

On World Laboratory Day, we highlight the teams behind our laboratory work. Their team leads share what matters in their area. At CeGaT, three specialized in-house laboratories ensure reliable results:

• Laboratory I – Isolation & External Quality Control (EQC)
The team isolates DNA and RNA and performs quality control for all incoming samples. They determine whether a sample is fit for sequencing. Any compromise at this stage affects everything downstream.

• Laboratory II – Next-Generation Sequencing
Library preparation and sequencing of in-house prepared samples and custom pools take place here. High-throughput workflows run under controlled conditions across all samples.

• Laboratory III – New Applications
This lab applies advanced long-read, single-cell, and spatial sequencing to answer our customers’ scientific questions. It continually explores and integrates new protocols into its workflow.

Adresse

Paul-Ehrlich-Straße 23
Tübingen
72076

Öffnungszeiten

Montag	08:00 - 18:00
Dienstag	08:00 - 16:30
Mittwoch	08:00 - 18:00
Donnerstag	08:00 - 18:00
Freitag	08:00 - 16:30

Telefon

+4970715654455

Webseite

https://www.cegat.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von CeGaT GmbH erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.